CD274 and neoplasm: The tumour growth curve reveals that different PLGA formulations promoted a significant reduction of tumour volume (p<0.0001, NP1 and NP3 including anti-PD-L1 pre-treatment) of ∼30% and ∼70% when compared to free OXA and saline-treated animals, respectively (Fig. 6).